{"id":"tiotropium-5-g-q-d","_chembl":null,"allNames":"tiotropium 5 µg q.d.","_dailymed":null,"mechanism":{"target":"M3","drugClass":"Muscarinic antagonist","explanation":"Tiotropium 5 µg q.d. works by blocking M3 muscarinic receptors in the lungs, which helps to relax the muscles around the airways and improve breathing. This action reduces symptoms of chronic obstructive pulmonary disease (COPD).","oneSentence":"Tiotropium 5 µg q.d. acts as a long-acting muscarinic antagonist, blocking M3 receptors in the airways to reduce bronchoconstriction."},"_scrapedAt":"2026-03-28T01:48:03.528Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T08:47:37.969933+00:00","fieldsConflicting":0,"overallConfidence":0.95},"trialDetails":[],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Tiotropium 5 µg q.d.","genericName":"tiotropium-5-g-q-d","companyName":"Pfizer Inc.","companyId":"pfizer","modality":"","firstApprovalDate":"","aiSummary":"","enrichmentLevel":5,"visitCount":4,"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T08:47:37.969933+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}